[Cost of treatment using portable infusion pumps for subcutaneous insulin. State of the experiment in Lyon].
Since the treatment of insulin-dependent diabetics by subcutaneous insulin infusion device is not chargeable to French Health Insurance, charitable associations have been created whose activities are now controlled by the hospitals. A study of the capital and revenue budget of one such association, ADENOTECH, in Lyon, shows that the direct cost of outpatient treatment by portable devices has gone down from 40 F to 22 F per day, of which half represents the capital cost and half running costs. This cost is 15 F more per day than an intensive course by three daily insulin injections.